These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 13824001)
1. Treatment of advanced breast cancer by yttrium-90 implantation of the pituitary. FORREST AP Acta Unio Int Contra Cancrum; 1959; 15():1089-92. PubMed ID: 13824001 [No Abstract] [Full Text] [Related]
2. [Implantation of radioactive yttrium (Y90) in the sella turcica in the treatment of breast and prostate carcinoma in the advanced stage (considerations on 21 cases)]. GOFFRINI P; FESANI F; PERACCHIA A Arch Ital Chir; 1959; 85():269-302. PubMed ID: 13850467 [No Abstract] [Full Text] [Related]
3. Screw-implantation of the pituitary with yttrium-90. FORREST AP; BLAIR DW; VALENTINE JM Lancet; 1958 Jul; 2(7039):192-3. PubMed ID: 13564797 [No Abstract] [Full Text] [Related]
4. Needle implantation of yttrium seeds for pituitary ablation in cases of secondary carcinoma. FRASER R; LAWS JW; JOPLIN GF; MORRISON R; STEINER RE Lancet; 1959 Feb; 1(7069):382-6. PubMed ID: 13632031 [No Abstract] [Full Text] [Related]
5. Implantation of radioactive material into the pituitary for the control of prostatic cancer: an interim review. FERGUSSON JD Br J Urol; 1957 Sep; 29(3):215-21. PubMed ID: 13471943 [No Abstract] [Full Text] [Related]
6. Implantation of the pituitary with yttrium90 in a case of Cushing's syndrome. MOLINATTI GM; CAMANNI F; TEDESCHI M J Clin Endocrinol Metab; 1959 Sep; 19():1144-50. PubMed ID: 14423367 [No Abstract] [Full Text] [Related]
7. [Implantation of intrapituitary radioactive material (Au-198 and Y-90) in metastatic cancers of the breast. Clinical and biological review apropos of 75 cases]. JURET P; HAYEM M Rev Fr Etud Clin Biol; 1961 Jan; 6():19-34. PubMed ID: 13791099 [No Abstract] [Full Text] [Related]
8. [The effect of pituitary destruction on choroid metastases following breast cancer]. BERINGER A; BURIAN K; ELLEGAST H; FANTA H; FRISCHAUF H Wien Klin Wochenschr; 1961 Dec; 73():844-5. PubMed ID: 13867841 [No Abstract] [Full Text] [Related]
9. [Contribution to the study of endocrine insufficiencies following the intraturcic implantation of radioactive yttrium]. BECK H; NORDMANN ; BARRE C; BERTHAUX P; LASSABLIERE C; VIGNALOU J Sem Hop; 1962 Apr; 38():1414-20. PubMed ID: 13866274 [No Abstract] [Full Text] [Related]
10. [THE METOPIRONE TEST IN BREAST CANCER OF AN ADVANCED STAGE, BEFORE AND AFTER PITUITARY IMPLANTATION OF YTTRIUM]. POMMATAU E; POULAIN S; COLON J Lyon Med; 1963 Nov; 210():1005-17. PubMed ID: 14097631 [No Abstract] [Full Text] [Related]
11. Yttrium implant for advanced breast cancer. Forrest AP; McFadyen I; Roberts MM; Stewart HJ; Sumerling M Prog Clin Biol Res; 1977; 12():483-92. PubMed ID: 335405 [No Abstract] [Full Text] [Related]
12. [HYPOPHYSIOLYSIS WITH RADIOACTIVE YTTRIUM IN THE TREATMENT OF ADVANCED BREAST CANCER]. COLON J; DUTOUT L; DARGENT M Lyon Chir; 1965 Jan; 61():94-5. PubMed ID: 14298515 [No Abstract] [Full Text] [Related]
14. THERAPEUTIC HYPOPITUITARISM INDUCED BY STEREOTAXIC TRANSFRONTAL IMPLANTATION OF YTTRIUM-90 IN PATIENTS WITH BREAST CANCER. JADRESIC A; POBLETE M; REID A; RIERA M; MATUS A; HERREROS M J Clin Endocrinol Metab; 1965 May; 25():686-97. PubMed ID: 14313763 [No Abstract] [Full Text] [Related]
15. Yttrium implantation of the hypophysis by the nasal route. IRONSIDE WM; MOSELEY RD; DE VOS WN Acta Unio Int Contra Cancrum; 1959; 15():1102-7. PubMed ID: 13853010 [No Abstract] [Full Text] [Related]
17. [PITUITARY DESTRUCTION BY STEREOTAXIC IMPLANTATION OF YTTRIUM 90 IN ADVANCED CANCER OF THE BREAST]. JADRESIC A; POBLETE M; RAHAUSEN A; PABST Y Rev Fr Endocrinol Clin; 1964; 5():491-7. PubMed ID: 14276409 [No Abstract] [Full Text] [Related]
18. [HYPOPHYSECTOMY WITH RADIOACTIVE YTTRIUM IN THE TREATMENT OF BREAST CANCER IN ADVANCED STAGES]. COLON J; DUTOUT L; DARGENT M Lyon Chir; 1964 Nov; 60():872-3. PubMed ID: 14268557 [No Abstract] [Full Text] [Related]
19. [VALUE OF THE METOPIRONE TEST AFTER PITUITARY IMPLANTATION OF YTTRIUM IN HORMONE-DEPENDENT CANCER. IMPORTANCE AND DISADVANTAGES OF THE REPLACEMENT OF CORTISONE THERAPY BY ALDOSTERONE]. POULAIN S; POMMATAU E; COLON J; DUTOU L Ann Endocrinol (Paris); 1964; 25():577-82. PubMed ID: 14208645 [No Abstract] [Full Text] [Related]
20. [Interstitial irradiation of the pituitary gland with yttrium 90]. DOGLIOTTI AM; RUFFO A; BADELLINO F; ROSSOTTO P; TRINCHIERI P Minerva Nucl; 1959; 3():239-41. PubMed ID: 13817232 [No Abstract] [Full Text] [Related] [Next] [New Search]